About >> Papers & Publications

Peer Reviewed Journal Publications

41. M R Feneley, M C Parkinson.  The clinical importance of prostatic intra-epithelial neoplasia. Current Medical Literature: Prostatic disease.  (1997), 1 (1), 4-6.
42. M R Feneley, M C Parkinson.  The clinical importance of prostatic intra-epithelial neoplasia. Current Medical Literature: Urology.  (1997), 3 (1), 3-5.
43. M R Feneley, M C Parkinson. Editorial: Biopsy diagnosis of prostatic cancer - current areas of concern. Journal of Clinical Pathology (1996), 50, 265-6.R S Kirby  and M R Feneley. Tissue effects of 5-alpha-reductase inhibitors. Prospectives (1997), 7 (5), 1-4.
44. M R Feneley, M C Parkinson.  The interpretation of prostatic needle biopsy specimens.  Prospectives (1996), 6, 5-8.
45. M R Feneley, D A Gillatt, M Hehir, R S Kirby.  A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome. British Journal of Urology (1996), 78, 911-20.
46. M R Feneley, M P A Young, C Makunura, R S Kirby, M C Parkinson. Ki-67 expression in early prostate cancer and associated pathological lesions. Journal of Clinical Pathology (1996), 49, 741-8.
47. M R Feneley, W D Dunsmuir, J Bryan, R S Kirby.  Reproducibility of uroflow measurements: experience during a double blind placebo controlled study of Doxazosin in benign prostatic hyperplasia.  Urology (1996), 47, 658-671.
48. M R Feneley, V U Chengazi, R S Kirby, C C Nimon, M Granowska, S J Mather, D Ellison, A R Granowski, K E Britton.  Prostatic immune-scintigraphy: preliminary results using technetium-labeled monoclonal antibody CYT-351.  British Journal of Urology (1996), 77, 373-381.
49. W Dunsmuir, M R Feneley, D A Corry, J Bryan, R S Kirby.  The day-to-day variation (test-retest reliability), of residual urine measurement.  British Journal of Urology (1996), 77, 192-193.
50. M R Feneley, R S Kirby, M C Parkinson. Prostatic malignancy following sclerotherapy: a diagnostic pitfall.  British Journal of Urology (1996), 77, 157-158.
51. M R Feneley. Study finds high prevalence of high grade PIN in UK; effects on screening programs, re-biopsy policy seen. Urology Grand Rounds, (1996), 1, 13.
52. M R Feneley, J Mooibroeck, E Chartier-Kastler, H U Eickenberg (Eds).  Urology Options No.4.  Conference Report.  3rd International Consultation on BPH, Monaco (1995), Yamanouchi.
53. M R Feneley, R S Kirby.  Reproducibility of Uroflow recordings.  European Urology Today (1995), 5, 6-7.